Total Payments
$3,284
2024 Payments
$1,412
Companies
18
Transactions
196
Medicare Patients
311
Medicare Billing
$29,254
Payment Breakdown by Category
Food & Beverage$3,037 (92.5%)
Education$246.98 (7.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,037 | 193 | 92.5% |
| Education | $246.98 | 3 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. | $812.17 | 58 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $786.63 | 62 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $416.22 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $341.39 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $228.79 | 9 | $0 (2024) |
| Alkermes, Inc. | $194.74 | 7 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $69.56 | 3 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $67.86 | 3 | $0 (2024) |
| Lilly USA, LLC | $56.04 | 4 | $0 (2023) |
| Mylan Specialty L.P. | $54.10 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,412 | 91 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($786.63) |
| 2023 | $883.39 | 61 | ITI, Inc. ($476.41) |
| 2022 | $686.51 | 36 | ITI, Inc. ($335.76) |
| 2018 | $44.32 | 2 | Alkermes, Inc. ($44.32) |
| 2017 | $258.42 | 6 | Alkermes, Inc. ($94.56) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.04 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $5.84 | General |
| Category: Narcoplepsy | ||||||
| 11/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 147 | 192 | $30,282 | $11,876 |
| 2022 | 6 | 164 | 234 | $32,715 | $17,377 |
Total Patients
311
Total Services
426
Medicare Billing
$29,254
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 77 | $11,820 | $6,123 | 51.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 47 | 51 | $8,160 | $2,509 | 30.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 17 | 17 | $5,270 | $1,471 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 23 | $2,392 | $1,050 | 43.9% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 22 | 24 | $2,640 | $722.97 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 69 | $10,592 | $6,458 | 61.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 74 | $7,696 | $4,804 | 62.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 27 | $5,589 | $2,654 | 47.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $4,752 | $1,667 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,826 | $1,188 | 42.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 30 | 36 | $1,260 | $607.03 | 48.2% |
About Dr. David Peyok, D.O
Dr. David Peyok, D.O is a Military Health Care Provider healthcare provider based in Stilwell, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2016. The National Provider Identifier (NPI) number assigned to this provider is 1639530769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Peyok, D.O has received a total of $3,284 in payments from pharmaceutical and medical device companies, with $1,412 received in 2024. These payments were reported across 196 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,037).
As a Medicare-enrolled provider, Peyok has provided services to 311 Medicare beneficiaries, totaling 426 services with total Medicare billing of $29,254. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Military Health Care Provider
- Other Specialties Psychiatry, Addiction Medicine
- Location Stilwell, OK
- Active Since 03/17/2016
- Last Updated 06/30/2022
- Taxonomy Code 171000000X
- Entity Type Individual
- NPI Number 1639530769
Products in Payments
- CAPLYTA (Drug) $1,599
- INVEGA SUSTENNA (Drug) $318.08
- AUSTEDO (Drug) $125.66
- ABILIFY MAINTENA (Drug) $109.79
- ABILIFY ASIMTUFII (Drug) $88.21
- Aristada 441 mg (Drug) $78.01
- INGREZZA (Drug) $69.56
- Vivitrol 380 mg (Drug) $60.87
- ARISTADA (Drug) $55.86
- XIFAXAN (Drug) $52.69
- PERSERIS (Drug) $46.74
- FANAPT (Drug) $45.88
- TRULICITY (Drug) $40.99
- Yupelri (Drug) $31.94
- REXULTI (Drug) $30.79
- UZEDY (Drug) $27.01
- SPRAVATO (Drug) $23.31
- COBENFY (Drug) $23.04
- YUPELRI (Drug) $22.16
- Fanapt (Drug) $21.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.